You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

CLINICAL TRIALS PROFILE FOR ACCOLATE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for Accolate

Trial ID Title Status Sponsor Phase Start Date Summary
NCT01283061 ↗ Bioequivalence Study of Zafirlukast Tablets 20 mg of Dr. Reddy's Laboratories Limited Under Fasting Condition Completed Dr. Reddy's Laboratories Limited Phase 1 2007-12-01 The objective of this study was to compare the relative bioavailability of zafirlukast tablets 20 mg with that of 'ACCOLATE®' tablets 20 mg (zafirlukast tablets 20 mg) in healthy, adult, human, subjects under fasting conditions and to monitor safety of subjects.
NCT02950480 ↗ Breast Capsular Contracture Following Post-Mastectomy Reconstruction in Women Treated With the Leukotriene Inhibitor Zafirlukast: A Phase II Trial Terminated University of California, San Francisco Phase 2 2017-03-13 A 2 arm, 90 patient (45 per cohort) trial in patients with breast cancer who will be undergoing mastectomy with immediate tissue-expander reconstruction to determine whether treatment with zafirlukast (20mg PO BID) can reduce or prevent the development of capsular contracture.
NCT04339140 ↗ Zafirlukast in Treatment of Marker Relapsed Ovarian Cancer Recruiting National Institutes of Health (NIH) Phase 2 2020-06-24 This research study is evaluating the effectiveness of Zafirlukast to prevent tumor activity in participants with tumor marker-only relapsed ovarian cancer. - The name of the study drug involved in this study is: - Zafirlukast
NCT04339140 ↗ Zafirlukast in Treatment of Marker Relapsed Ovarian Cancer Recruiting Dana-Farber Cancer Institute Phase 2 2020-06-24 This research study is evaluating the effectiveness of Zafirlukast to prevent tumor activity in participants with tumor marker-only relapsed ovarian cancer. - The name of the study drug involved in this study is: - Zafirlukast
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Accolate

Condition Name

Condition Name for Accolate
Intervention Trials
Biological Tumor Markers 1
Breast Cancer 1
Healthy 1
Ovarian Cancer 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Accolate
Intervention Trials
Ovarian Neoplasms 1
Carcinoma, Ovarian Epithelial 1
Contracture 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Accolate

Trials by Country

Trials by Country for Accolate
Location Trials
United States 2
India 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Accolate
Location Trials
Massachusetts 1
California 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Accolate

Clinical Trial Phase

Clinical Trial Phase for Accolate
Clinical Trial Phase Trials
Phase 2 2
Phase 1 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Accolate
Clinical Trial Phase Trials
Completed 1
Recruiting 1
Terminated 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Accolate

Sponsor Name

Sponsor Name for Accolate
Sponsor Trials
Dr. Reddy's Laboratories Limited 1
University of California, San Francisco 1
National Institutes of Health (NIH) 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Accolate
Sponsor Trials
Other 2
NIH 1
Industry 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.